▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #941 by analyst upside · 2026-08-12
SGP
SpyGlass Pharma, Inc.
Healthcare · Market Cap $831M · P/E 0x
ANALYST PRICE TARGET
+81.1%
implied upside to consensus target
Current Price $24.85
Consensus Target $45.0
Bull Target $62.0
Bear Target $37.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
5
Hold
0
Sell
0
52-Week Low $17.06
52-Week High $32.44
YTD Return -5.9%
FUNDAMENTALS
Market Cap $831M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.67
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $17.06
52-Week High $32.44
Current Price $24.85
Bear Target $37.0
Bull Target $62.0
● Now $24.85 ● Target $45.0
TRADING DATA
Avg Volume 111K
YTD Return -5.9%
Analyst Count 5
Consensus Buy
Upside to Target +81.1%
Last Updated 2026-08-12

ANALYST SUMMARY

SpyGlass Pharma, Inc. (SGP) is currently trading at $24.85 with a Wall Street consensus price target of $45.0, implying potential upside of 81.1% over the next 12 months. 5 analysts currently cover SGP, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $62.0, while the most cautious has a target of $37.0.

SGP operates in the Healthcare sector with a market capitalisation of $831M. The stock is down 5.9% year-to-date and is currently trading near the upper end of its 52-week range of $17.06 – $32.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

GMRS +62.8%
GMR Solutions Inc.
$643M · P/E 6.2x · Buy
COLL +97.1%
Collegium Pharmaceutical, Inc.
$843M · P/E 20.5x · Buy
NUTX +60.0%
Nutex Health Inc.
$1B · P/E 6.5x · Buy
CRMD +105.5%
CorMedix Inc.
$573M · P/E 3.4x · Strong Buy
IRWD +41.9%
Ironwood Pharmaceuticals, Inc.
$711M · P/E 5.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for SGP, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. ● Initiated
Buy 2026-03-10 31% win rate (48 calls)
Citigroup ● Initiated
Buy 2026-03-03 Building track record
Leerink Partners ● Initiated
Outperform 2026-03-03 29% win rate (7 calls)
Jefferies ● Initiated
Buy 2026-03-03 50% win rate (6 calls)
Stifel ● Initiated
Buy 2026-03-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
14/30
Consensus clarity
10/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →